Co-Authors
This is a "connection" page, showing publications co-authored by Lawrence Kushi and Jacek Skarbinski.
Connection Strength
1.799
-
Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study. Lancet Reg Health Am. 2022 Aug; 12:100297.
Score: 0.789
-
COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults With Cancer. JAMA Oncol. 2025 Sep 01; 11(9):999-1010.
Score: 0.246
-
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system. PLoS One. 2024; 19(6):e0303303.
Score: 0.227
-
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system. medRxiv. 2024 Feb 02.
Score: 0.221
-
Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. Open Forum Infect Dis. 2022 Jun; 9(6):ofac171.
Score: 0.195
-
COVID-19 Vaccine Booster Uptake and Effectiveness Among Persons With Systemic Autoimmune and Rheumatic Diseases. J Rheumatol. 2025 Sep 01.
Score: 0.062
-
In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patients. J Natl Cancer Inst. 2025 Mar 24.
Score: 0.060